positive
Integris Medtech files DRHP with SEBI for ₹3,500–4,000 crore IPO
Everstone-backed Integris Medtech has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise between ₹3,500 crore and ₹4,000 crore. The issue includes a fresh equity component of ₹925 crore and an offer-for-sale (OFS) of 2.16 crore shares by promoters and existing investors. The firm operates in medical devices, diagnostics, and lab automation, with FY25 revenue at ₹1,959.58 crore. Proceeds will fund expansion, debt reduction, and R&D capacity building across India and global subsidiaries.
Companies:
- Integris Medtech
Tags:
- Integris Medtech
- IPO India
Explore:High Return Equity Mutual Fund
positive
Integris Medtech files DRHP with SEBI for ₹3,500–4,000 crore IPO
Everstone-backed Integris Medtech has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise between ₹3,500 crore and ₹4,000 crore. The issue includes a fresh equity component of ₹925 crore and an offer-for-sale (OFS) of 2.16 crore shares by promoters and existing investors. The firm operates in medical devices, diagnostics, and lab automation, with FY25 revenue at ₹1,959.58 crore. Proceeds will fund expansion, debt reduction, and R&D capacity building across India and global subsidiaries.
Companies:
- Integris Medtech
Tags:
- Integris Medtech
- IPO India
Explore:High Return Equity Mutual Fund
1 min read
75 words
Integris Medtech filed for a ₹3,500–4,000 crore IPO, combining fresh issue and OFS to fund expansion and strengthen balance sheet.
Everstone-backed Integris Medtech has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise between ₹3,500 crore and ₹4,000 crore. The issue includes a fresh equity component of ₹925 crore and an offer-for-sale (OFS) of 2.16 crore shares by promoters and existing investors. The firm operates in medical devices, diagnostics, and lab automation, with FY25 revenue at ₹1,959.58 crore. Proceeds will fund expansion, debt reduction, and R&D capacity building across India and global subsidiaries.
Everstone-backed Integris Medtech has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise between ₹3,500 crore and ₹4,000 crore. The issue includes a fresh equity component of ₹925 crore and an offer-for-sale (OFS) of 2.16 crore shares by promoters and existing investors. The firm operates in medical devices, diagnostics, and lab automation, with FY25 revenue at ₹1,959.58 crore. Proceeds will fund expansion, debt reduction, and R&D capacity building across India and global subsidiaries.
Companies:
- Integris Medtech
Tags:
- Integris Medtech
- IPO India
- Integris Medtech
- IPO India
- DRHP
- medical devices
- Everstone